Literature DB >> 23019260

Bid signal pathway components are identified in the temporal cortex with Parkinson disease.

Hong Jiang1, Ping He, Charles H Adler, Holly Shill, Thomas G Beach, Rena Li, Yong Shen.   

Abstract

OBJECTIVE: Parkinson disease (PD), a devastating neurodegenerative disorder, affects motor abilities and cognition as well. It is not clear whether the proapoptotic protein, Bid, is involved in tumor necrosis factor death receptor I (TNFRI)-mediated destructive signal transduction pathways such as cell dysfunction or neurodegeneration in the temporal cortex of patients with PD.
METHODS: Molecular and biochemical approaches were used to dissect mitochondrial related components of the destructive signaling pathway in the temporal cortex from rapidly autopsied brains (postmortem interval mean 2.6 hours). Brains from patients with PD (n = 15) had an average age of 81.4 years, compared to the average age of 84.36 years in age-matched control patient brains (n = 15).
RESULTS: TNFRI and its adaptor protein, TRADD, were not only present in the cytoplasm of the temporal cortex, but were significantly elevated (42.3% and 136.1%, respectively) in PD brains compared to age-matched control brains. Bid in the PD temporal cortex could be further cleaved into tBid in the cytosol, which is translocated into the mitochondria, where cytochrome c is then released and caspase-3 is subsequently activated.
CONCLUSION: Patients with PD have an activated Bid-mediated destructive signal pathway via TNFRI in the temporal cortex. Such deficits are pervasive, suggesting that they might contribute to cortex degeneration as PD manifests.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019260      PMCID: PMC3475620          DOI: 10.1212/WNL.0b013e3182703f76

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

Review 1.  Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

Authors:  Andreas Hald; Julie Lotharius
Journal:  Exp Neurol       Date:  2005-06       Impact factor: 5.330

Review 2.  Neuroinflammatory processes in Parkinson's disease.

Authors:  Etienne C Hirsch; Stéphane Hunot; Andreas Hartmann
Journal:  Parkinsonism Relat Disord       Date:  2005-06       Impact factor: 4.891

Review 3.  Inflammatory process in Parkinson's disease: role for cytokines.

Authors:  T Nagatsu; M Sawada
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

4.  A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis.

Authors:  N A Thornberry; T A Rano; E P Peterson; D M Rasper; T Timkey; M Garcia-Calvo; V M Houtzager; P A Nordstrom; S Roy; J P Vaillancourt; K T Chapman; D W Nicholson
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

5.  Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

Authors:  H Li; H Zhu; C J Xu; J Yuan
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

6.  Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

Authors:  X Luo; I Budihardjo; H Zou; C Slaughter; X Wang
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

7.  Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death.

Authors:  A Gross; X M Yin; K Wang; M C Wei; J Jockel; C Milliman; H Erdjument-Bromage; P Tempst; S J Korsmeyer
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.

Authors:  S Desagher; A Osen-Sand; A Nichols; R Eskes; S Montessuit; S Lauper; K Maundrell; B Antonsson; J C Martinou
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

View more
  5 in total

1.  Cortical gray and subcortical white matter associations in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2016-09-28       Impact factor: 4.673

2.  The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments.

Authors:  Lihua Li; Bingjun Ji; Ting Zhao; Xuan Cui; Jingtao Chen; Zhenyu Wang
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

3.  Stage-dependent loss of cortical gyrification as Parkinson disease "unfolds".

Authors:  Nicholas W Sterling; Ming Wang; Lijun Zhang; Eun-Young Lee; Guangwei Du; Mechelle M Lewis; Martin Styner; Xuemei Huang
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910

Review 4.  Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities.

Authors:  Sana Javaid; Talha Farooq; Zohabia Rehman; Ammara Afzal; Waseem Ashraf; Muhammad Fawad Rasool; Faleh Alqahtani; Sary Alsanea; Fawaz Alasmari; Mohammed Mufadhe Alanazi; Metab Alharbi; Imran Imran
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

Review 5.  Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression.

Authors:  N W Sterling; M M Lewis; G Du; X Huang
Journal:  J Parkinsons Dis       Date:  2016-05-27       Impact factor: 5.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.